Cutler Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,700
| Closed | -$10K | – | 4978 |
|
|
2022
Q4 | $10K | Buy |
+1,700
| New | +$110K | ﹤0.01% | 2735 |
|
|
2022
Q3 | – | Sell |
-1,000
| Closed | -$1K | – | 5708 |
|
|
2022
Q2 | $1K | Buy |
+1,000
| New | +$63.6K | ﹤0.01% | 4815 |
|
|
2022
Q1 | – | Sell |
-4,600
| Closed | -$22K | – | 6279 |
|
|
2021
Q4 | $22K | Sell |
4,600
-20,400
| -82% | -$3.17M | ﹤0.01% | 3061 |
|
|
2021
Q3 | $67K | Buy |
+25,000
| New | +$4.02M | ﹤0.01% | 2270 |
|
|
2021
Q1 | – | Sell |
-8,100
| Closed | -$1K | – | 6487 |
|
|
2020
Q4 | $1K | Sell |
8,100
-500
| -6% | -$108K | ﹤0.01% | 4658 |
|
|
2020
Q3 | $49K | Sell |
8,600
-2,200
| -20% | -$301K | ﹤0.01% | 1817 |
|
|
2020
Q2 | $74K | Sell |
10,800
-5,600
| -34% | -$543K | ﹤0.01% | 1488 |
|
|
2020
Q1 | $215K | Buy |
16,400
+3,900
| +31% | +$350K | 0.01% | 910 |
|
|
2019
Q4 | $124K | Buy |
12,500
+5,300
| +74% | +$511K | 0.01% | 1085 |
|
|
2019
Q3 | $271K | Sell |
7,200
-7,000
| -49% | -$657K | 0.02% | 564 |
|
|
2019
Q2 | $134K | Buy |
14,200
+4,800
| +51% | +$374K | 0.01% | 940 |
|
|
2019
Q1 | $15K | Buy |
9,400
+4,800
| +104% | +$327K | ﹤0.01% | 2247 |
|
|
2018
Q4 | $1K | Sell |
4,600
-35,300
| -88% | -$1.41M | ﹤0.01% | 3762 |
|
|
2018
Q3 | $515K | Buy |
39,900
+27,900
| +233% | +$1.55M | 0.04% | 455 |
|
|
2018
Q2 | $15K | Buy |
+12,000
| New | +$453K | ﹤0.01% | 2410 |
|
|
2018
Q1 | – | Sell |
-8,500
| Closed | -$4K | – | 5423 |
|
|
2017
Q4 | $4K | Sell |
8,500
-5,000
| -37% | -$77.6K | ﹤0.01% | 3860 |
|
|
2017
Q3 | $16K | Buy |
13,500
+5,100
| +61% | +$29.5K | ﹤0.01% | 3370 |
|
|
2017
Q2 | $17K | Sell |
8,400
-7,100
| -46% | -$27.2K | ﹤0.01% | 3610 |
|
|
2017
Q1 | $38K | Buy |
15,500
+3,700
| +31% | +$20.3K | ﹤0.01% | 2680 |
|
|
2016
Q4 | $29K | Buy |
11,800
+10,800
| +1,080% | +$58.8K | ﹤0.01% | 3102 |
|
|
2016
Q3 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 5854 |
|
|
2016
Q2 | $3K | Buy |
+1,000
| New | +$15.9K | ﹤0.01% | 5470 |
|
|
2016
Q1 | – | Sell |
-1,200
| Closed | -$8K | – | 7394 |
|
|
2015
Q4 | $8K | Buy |
+1,200
| New | +$42.4K | ﹤0.01% | 4448 |
|
Other funds holding MRTX
Cutler Group's MRTX Position: Q1 2024 in Review
Cutler Group sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 1,500 shares — an estimated $88K sold.
Cutler Group first reported a position in MRTX in Q4 2015 and held it in 26 quarters. The position peaked at $3.6M in Q3 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- Cutler Group reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Cutler Group sold 1,500 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $88K.
- Cutler Group first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2015 and held it in 26 quarters.
- Cutler Group's Mirati Therapeutics, Inc. Common Stock position peaked at $3.6M in Q3 2021.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.